Revenio Group Oyj (REG1V) Earnings Call Transcripts
Revenio Group Oyj's Latest Earnings Call - April 13, 2026
In the first quarter of fiscal year 2026, Visionix Ltd. announced a significant acquisition of Visionix, which is expected to enhance its product portfolio and expand its market reach from EUR 1 billion to EUR 2.5 billion. The deal is valued at EUR 290 million, with expected synergies of EUR 20 million by the end of 2027. Management indicated that the combined company would target a 25% EBITDA margin by 2028-2029, reflecting a strong commitment to growth and profitability improvements.
Reported metrics
| Metric | Value |
|---|---|
| Acquisition Value | EUR 290 million (positive) |
| Market Size Increase | EUR 2.5 billion (positive) |
| Synergies Target | EUR 20 million (positive) |
| EBITDA Margin Target | 25% (positive) |
| Debt Financing | EUR 130 million (neutral) |
| Sales Growth Rate | 3x faster than market (positive) |
Guidance from management
Management withdrew previous guidance and will provide new guidance after the completion of the Visionix acquisition, targeting a 25% EBITDA margin by 2028-2029.
What management said
Thank you, Arne. And perhaps the continuation question, which goes for Charles. So it has been clear since beginning when talking with Marc when talking with you, Charles, that you are not just selling, say, Visionix shareholder the shares out, but you are committed to the longer-term journey. So can you a bit explain that logic for us? Also, I think you are going to subscribe the shares with the higher price where ...
Thank you. Thank you, Charles. And perhaps giving another shareholder spin on this one. So Arne, are you a bit able to open the logic? So William Demant, our biggest shareholder, almost owning roughly 25% of the shares is also committed in a long run. So from the all shareholders' perspective, are you able to open that one a bit?
What analysts pressed on
Analysts expressed concerns regarding the historical growth trajectory of Visionix, particularly its flat performance in recent years. Questions were raised about integration challenges and the potential impact of overlapping products on sales.
Main topics on the call
- Acquisition of Visionix — Visionix has signed a deal to acquire Visionix for EUR 290 million, which will significantly enhance its product offerings and market presence. CEO Jouni Toijala stated, "This is a significant day for us as a revenue and...
- Market Expansion — The acquisition will increase the accessible market from EUR 1 billion to EUR 2.5 billion, with a focus on high-growth segments like OCT devices. Toijala noted, "We are really able to accelerate the growth," emphasizing ...
- Synergy Realization — Management targets EUR 20 million in synergies, with 70% expected to be realized by the end of 2027. CFO Robin Pulkkinen highlighted that "the fastest is Spain because we closest done," indicating immediate opportunities...
- Financial Guidance — The company withdrew its previous guidance and will provide new guidance post-transaction completion. They aim for a 25% EBITDA margin by 2028-2029, as stated by Toijala, "We are committed to grow 3x faster than the mark...
Read the full Revenio Group Oyj transcript (April 13, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Revenio Group Oyj
Revenio Group Oyj (REG1V) is a publicly listed company in the Health Care Equipment and Supplies industry, within the Health Care sector. It trades on HLSE and is based in FI. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 25 calls on record spanning February 20, 2020 to September 8, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 25 Revenio Group Oyj earnings call transcripts on record, spanning February 20, 2020 to September 8, 2026. Based on this history, Revenio Group Oyj reports quarterly. The most recent call on file is dated September 8, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- REG1V
- Exchange
- HLSE
- Country
- FI
- Sector
- Health Care
- Calls on record
- 25
- First call
- February 20, 2020
- Most recent
- September 8, 2026
- Reporting cadence
- quarterly